FDA tentatively OKs Yabao’s generic Nexavar

The FDA has tentatively approved Chinese drug maker Yabao Pharmaceutical Group Limited’s sorafenib tosylate. Sorafenib is the active ingredient in Bayer’s (OTCPK:BAYRY -0.7%) cancer med Nexavar (sorafenib).

Tentative approval means that the application met the criteria for approval but patent issues need to be resolved before full approval is granted.

https://seekingalpha.com/news/3477449-fda-tentatively-oks-yabaos-generic-nexavar